Neuropsychological, neuropsychiatric, and quality‐of‐life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study

202134 citationsJournal Articlegreen Open Access

Authors

Merçé Boada · Instituto de Salud Carlos III

Oscar L. López · University of Pittsburgh

Javier Olazarán · Hospital General Universitario Gregorio Marañón

Laura Núñez · Grifols (Spain)

Michael A. Pfeffer · Allied Biomedical Research Institute

Orlando Puente · Miami Dade College

Gerard Piñol‐Ripoll

Abstract

PE-treated AD patients showed improvement in memory, language abilities, processing speed, and QoL-AD. No worsening of their psychoaffective status was observed.

Topics & Keywords

Alzheimer's disease research and treatments Dementia and Cognitive Impairment Research Pharmacological Effects and Toxicity Studies

UN Sustainable Development Goals

Quality Education

Publication Details

Published in: Alzheimer s & Dementia

Volume 18, Issue 7, pp. 1314-1324

DOI: 10.1002/alz.12477

Field-Weighted Citation Impact: 3.60